Vectus Biosystems Limited

Vectus Biosystems Limitedverified

VBS.AX

Price:

$0.11

Market Cap:

$5.87M

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. ...[Read more]

Industry

Biotechnology

IPO Date

2016-02-22

Stock Exchange

ASX

Ticker

VBS.AX

The Enterprise Value as of December 2025 (TTM) for Vectus Biosystems Limited (VBS.AX) is 5.82M

According to Vectus Biosystems Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 5.82M. This represents a change of 2.97% compared to the average of 5.65M of the last 4 quarters.

Vectus Biosystems Limited (VBS.AX) Historical Enterprise Value (quarterly & annually)

How has VBS.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Vectus Biosystems Limited over the last ten years is 21.67M. The current 5.82M Enterprise Value has changed 2.58% with respect to the historical average. Over the past ten years (40 quarters), VBS.AX's Enterprise Value was at its highest in in the December 2021 quarter at 50.02M. The Enterprise Value was at its lowest in in the December 2011 quarter at 0.

Quarterly (TTM)
Annual

Average

21.67M

Median

21.64M

Minimum

2.08M

Maximum

40.94M

Vectus Biosystems Limited (VBS.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vectus Biosystems Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 173.68%

Maximum Annual Enterprise Value = 40.94M

Minimum Annual Increase = -82.09%

Minimum Annual Enterprise Value = 2.08M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20252.08M-36.34%
20243.26M-82.09%
202318.22M-52.68%
202238.50M-5.96%
202140.94M81.61%
202022.54M128.33%
20199.87M-52.40%
201820.74M-35.57%
201732.19M13.49%
201628.36M173.68%

Vectus Biosystems Limited (VBS.AX) Average Enterprise Value

How has VBS.AX Enterprise Value performed in the past?

The current Enterprise Value of Vectus Biosystems Limited (VBS.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

7.85M

5-year avg

20.60M

10-year avg

21.67M

Vectus Biosystems Limited (VBS.AX) Enterprise Value vs. Peers

How is VBS.AX’s Enterprise Value compared to its peers?

Vectus Biosystems Limited’s Enterprise Value is less than Bio-Gene Technology Limited (6.84M), greater than Invex Therapeutics Ltd (3.64M), less than Adherium Limited (10.78M), greater than Biotron Limited (4.05M), less than Acrux Limited (9.34M), less than Cann Group Limited (81.46M), less than Invion Limited (7.37M), greater than InhaleRx Limited (5.34M), less than HITIQ Limited (17.35M), less than Memphasys Limited (14.63M),

Build a custom stock screener for Vectus Biosystems Limited (VBS.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vectus Biosystems Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vectus Biosystems Limited (VBS.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vectus Biosystems Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Vectus Biosystems Limited's Enterprise Value?

What is the highest Enterprise Value for Vectus Biosystems Limited (VBS.AX)?

What is the 3-year average Enterprise Value for Vectus Biosystems Limited (VBS.AX)?

What is the 5-year average Enterprise Value for Vectus Biosystems Limited (VBS.AX)?

How does the current Enterprise Value for Vectus Biosystems Limited (VBS.AX) compare to its historical average?